Search research articles
Contact Us
Filters
Showing results (81-90 of 122) with videos related to
Page
of 13
Sort By:
Bone
|
April 12, 2025
Craniosynostosis among children with X-linked hypophosphatemia: A systematic review and meta-analysis
Samuel A Fisch, Alina Tudor, El Mahdi Benchekroun, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
December 9, 2021
Musculoskeletal Comorbidities and Quality of Life in ENPP1-Deficient Adults and the Response of Enthesopathy to Enzyme Replacement Therapy in Murine Models
Carlos R Ferreira, Anenya Jai Ansh, Catherine Nester, et al.
Clinical Therapeutics
|
October 4, 2011
Bioavailability and short-term tolerability of alendronate in glucocorticoid-treated children
Meranda Nakhla, Andrew E Denker, James D Connor, et al.
JBMR Plus
|
November 4, 2025
Delayed diagnosis of X-linked hypophosphatemia in the absence of family history: a global unmet need
Suma Uday, M Zulf Mughal, Hamilton Cassinelli, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 4, 2026
Real-world Effectiveness of Burosumab Across Age Groups: X-linked Hypophosphatemia (XLH) Disease Monitoring Program
Leanne M Ward, Thomas O Carpenter, Hamilton Cassinelli, et al.
Bone
|
September 17, 2025
Advancing Patient Evidence in XLH (APEX): Baseline analysis of a global data unification program
Thomas O Carpenter, Seiji Fukumoto, Dieter Haffner, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 30, 2026
Real-world Impact of Treatment on Growth in Children With X-Linked Hypophosphatemia
Seiji Fukumoto, Dieter Haffner, Erik A Imel, et al.
The Journal of Clinical Investigation
|
February 27, 2014
Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia
Thomas O Carpenter, Erik A Imel, Mary D Ruppe, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
December 18, 2020
Burosumab for the Treatment of Tumor-Induced Osteomalacia
Suzanne M Jan de Beur, Paul D Miller, Thomas J Weber, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry
|
April 30, 2008
Dual energy X-ray absorptiometry interpretation and reporting in children and adolescents: the 2007 ISCD Pediatric Official Positions
Catherine M Gordon, Laura K Bachrach, Thomas O Carpenter, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 122) with videos related to
Sort By:
Page
of 13
Bone
|
April 12, 2025
Craniosynostosis among children with X-linked hypophosphatemia: A systematic review and meta-analysis
Samuel A Fisch, Alina Tudor, El Mahdi Benchekroun, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
December 9, 2021
Musculoskeletal Comorbidities and Quality of Life in ENPP1-Deficient Adults and the Response of Enthesopathy to Enzyme Replacement Therapy in Murine Models
Carlos R Ferreira, Anenya Jai Ansh, Catherine Nester, et al.
Clinical Therapeutics
|
October 4, 2011
Bioavailability and short-term tolerability of alendronate in glucocorticoid-treated children
Meranda Nakhla, Andrew E Denker, James D Connor, et al.
JBMR Plus
|
November 4, 2025
Delayed diagnosis of X-linked hypophosphatemia in the absence of family history: a global unmet need
Suma Uday, M Zulf Mughal, Hamilton Cassinelli, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 4, 2026
Real-world Effectiveness of Burosumab Across Age Groups: X-linked Hypophosphatemia (XLH) Disease Monitoring Program
Leanne M Ward, Thomas O Carpenter, Hamilton Cassinelli, et al.
Bone
|
September 17, 2025
Advancing Patient Evidence in XLH (APEX): Baseline analysis of a global data unification program
Thomas O Carpenter, Seiji Fukumoto, Dieter Haffner, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 30, 2026
Real-world Impact of Treatment on Growth in Children With X-Linked Hypophosphatemia
Seiji Fukumoto, Dieter Haffner, Erik A Imel, et al.
The Journal of Clinical Investigation
|
February 27, 2014
Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia
Thomas O Carpenter, Erik A Imel, Mary D Ruppe, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
December 18, 2020
Burosumab for the Treatment of Tumor-Induced Osteomalacia
Suzanne M Jan de Beur, Paul D Miller, Thomas J Weber, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry
|
April 30, 2008
Dual energy X-ray absorptiometry interpretation and reporting in children and adolescents: the 2007 ISCD Pediatric Official Positions
Catherine M Gordon, Laura K Bachrach, Thomas O Carpenter, et al.
Page
of 13